MarketPeel
Pricing
…
General Counsel
Jason Drew Smith
Thu, Oct 1, 2020
Oct 1
received an award in URGN
25,000 shares @ $0.00
New position
URGNUroGen Pharma Ltd.
HealthcareBiotechnology
1D0.00%
1W-2.82%
1M+14.38%
3M—
6M—
1Y—

Recent insider activity at URGN

Jul 9Mark SchoenbergSold$400.00kJun 22Mark SchoenbergSold$350.10kJun 8Mark SchoenbergSold$142.56kMay 8Mark SchoenbergSold$300.00kFeb 3Jason Drew SmithSold$31.66kFeb 3Jason Drew SmithSold$63.34kFeb 3Jason Drew SmithSold$52.26kFeb 3Mark SchoenbergSold$36.29k
Full URGN profile →Jason Drew Smith’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback